This opportunity is currently closed.

Sign up for Content alerts to stay informed when this or related funding opportunities are posted.


Junior Investigator Global ATTR Amyloidosis Research ASPIRE


The Junior Investigator Global ATTR Amyloidosis Research ASPIRE from Pfizer supports early-career principal investigators worldwide (except for the USA) working on ATTR Amyloidosis. The grant seeks to fund projects on:

  • Epidemiologic evaluations for ATTR amyloidosis
  • Approaches for the early identification and follow up of ATTR amyloidosis patients
  • RW efficacy and safety of tafamidis in the clinical setting for the management of ATTR amyloidosis
  • Evaluation of patients with ATTR-CM presenting with a mixed phenotype (e.g. cardiomyopathy and polyneuropathy)
  • Pathophysiology

The applicant must be affiliated with a research institution outside of the USA and have obtained their terminal degree within the past 10 years. Applicants may apply for up to 75,000 USD/year in funding support (including up to 28% of overheads) for 1-2 years.

Applications close on March 21, 2023.

Full application due:
March 21, 2023

Related Grants

Register for free

Don´t have an account?

Start with our free trial to enjoy our 7 days of unlimited grant access and our premium features.

or, Choose a plan to subscribe to our premium membership.

Be the first to know

Sign-up for Personalized Grant alerts


Sign-up for our
monthly research
funding newsletter

You can unsubscribe at any time.